Why the study?
Guidelines state that improving survival in ruptured abdominal aortic aneurysm requires an emergency management protocol, but whether introducing such a protocol improves clinical outcomes compared with a pre-protocol strategy remained to be investigated.
Does a protocol-based treatment reduce mortality in patients with ruptured abdominal aortic aneurysm compared to a pre-protocol strategy?
Does a protocol-based treatment reduce mortality in patients with ruptured abdominal aortic aneurysm compared to a pre-protocol strategy?
Implementing a standardized protocol for the emergency management of ruptured abdominal aortic aneurysms significantly reduces aorta-related mortality up to 1 year postoperatively.
Supports standardized rAAA protocols; hypothesis-generating and should not yet change practice pending RCTs.
BACKGROUND: Recent guidelines state that improving the survival rate of patients with ruptured abdominal aortic aneurysm (rAAA) requires a protocol or algorithm for the emergency management of these patients. We aimed to investigate whether introducing a protocol treatment for rAAA improves clinical outcomes compared with the pre-protocol strategy. METHODS: At our institution, 92 patients treated for rAAA between June 2008 and August 2022 were retrospectively analyzed. In 2014, the protocol-based treatment was introduced comprising a transfer algorithm to shorten the time to proximal control, use of an endovascular occlusion balloon, strict indications for endovascular aortic aneurysm repair (EVAR) or open surgical repair, and perioperative care, including for abdominal compartment syndrome (ACS). Clinical outcomes were compared between the protocol and pre-protocol group, including operative status, all-cause mortality, and rAAA-related death at 30-day, in-hospital, and 1-year postoperative follow-ups. RESULTS: Overall, 52 and 40 patients received the protocol-based and pre-protocol treatments, respectively. EVAR was more frequently performed in the protocol group. The rate of achieving time to proximal control was significantly faster, and the transfusion volume was lower in the protocol group. ACS occurred more frequently in the protocol group with a higher EVAR. No difference was found in all-cause mortality between the two groups. The protocol group exhibited fewer rAAA-related deaths than the pre-protocol group during the following time points: 30 days (9.6% vs. 22.5%), during the hospital stay (11.5% vs. 30.0%), and 1 year (14.5% vs. 31.5%). CONCLUSIONS: The protocol-based treatment improved the survival rate of patients with rAAA.
No takes yet. Share an insight, caveat, or question.
Takei et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: